miR-185-5p alleviates CCI-induced neuropathic pain by repressing NLRP3 inflammasome through dual targeting MyD88 and CXCR4
Authors:
- 6 January 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 104, 108508
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Advances in the Treatment of Neuropathic Pain2016
- Downregulation of microRNA-218 relieves neuropathic pain by regulating suppressor of cytokine signaling 3International Journal of Molecular Medicine, 2016
- Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for BiomarkersPLOS ONE, 2015
- Microglia in the spinal cord and neuropathic painJournal of Diabetes Investigation, 2015
- Suppression of MicroRNA-155 Attenuates Neuropathic Pain by Regulating SOCS1 Signalling PathwayNeurochemical Research, 2014
- MyD88: a central player in innate immune signalingF1000Prime Reports, 2014
- MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditionsNeurobiology of Disease, 2014
- Inhibitors of CXC chemokine receptor type 4Current Opinion in Hematology, 2014
- Neuroinflammation and the generation of neuropathic painBritish Journal of Anaesthesia, 2013
- CXC Chemokine Receptors in the Central Nervous System: Role in Cerebellar Neuromodulation and DevelopmentJournal of NeuroVirology, 2002